中国临床药学杂志

目的探索肿瘤患者长处方互联网管理模式的建立并评价其实施效果。方法通过制定服务流程、管理规范和质控项目,建立肿瘤患者长处方互联网管理模式。统计分析医院自建立与实施该模式6个月以来云诊室药品的应用情况,对云诊室处方超说明书进行专项点评,并对云诊室患者进行电话随访。结果 2020年2月12日至8月11日,共调配和快递1 705张云诊室长处方,合计2 000条药品条目数。45.70% (n=914)的药品处方疗程≤30 d,10.75% (n=215)的药品处方疗程为31～60 d,43.55% (n=871)的药品处方疗程> 60 d。对2020年2月12日至6月30日的1 651条云诊室药品条目进行超说明书专项点评,其中92条(5.6%)存在超说明书用药。抽取152例接受云诊室药品服务的患者进行电话随访,对药品云快递服务、目前开放的云诊室药品目录和对药师提供的药品说明用法用量表示非常满意或满意的患者占比分别是98.03%、99.34%和99.34%,90.79%的患者表示非常愿意或愿意接受临床药师的随访。结论初步建立肿瘤患者长处方互联网管理模式,该模式的实施使肿瘤患者的长期口服用药得到保障,获得肿瘤患者的广泛好评。同时,需要进一步加强对长处方药物的后续随访管理。

AIM To explore the establishment of long-term prescription network model for cancer patients and evaluate its implementing effect. METHODS We established the working mode of long-term prescription network model for cancer patients, including work flow, management practice and quality standard. After the implementation of the model in our hospital for six months, the application of the Cloud Clinic's drugs, the prescription comments of the offlabel use of the Cloud Clinic's prescription and satisfaction of patients were evaluated and analyzed. RESULTS A total of 1 705 prescriptions, including 2 000 drugs, were dispensed and delivered from February 12, 2020 to August 11, 2020. The prescribed course of the drugs was ≤ 30 d(n=914, 45.70%), 30-60 d(n=215, 10.75%), >60 d(n=871, 43.55%). The special prescription comment of off-label drug use was analyzed in the Cloud Clinic's 1 651 medical orders between February 12, 2020 to June 30, 2020. The rate of off-label drug use medical orders was 92(5.6%). A telephone followup was conducted among 152 patients who were prescribed by the Cloud Clinic. The patients were very satisfied or satisfied with the drug express service of the Cloud Clinic(98.03%), currently drug list of the Cloud Clinic(99.34%) and the use and dosage of the drug provided by the pharmacist(99.34%). The 90.79% patients were very willing or willing to be followed up by clinical pharmacists. CONCLUSION A long-term prescription network model has been initially established. The mode not only ensures the continuity of long-term medication for cancer patients, but also is widely praised by cancer patients. At the same time, it is necessary to further strengthen the follow-up management of the longterm prescription drugs.